Pig Colostrum Milk (Sus scrofa domesticus)

Pig colostrum (Sus scrofa domesticus) is the first milk produced by sows after farrowing, dense in immunoglobulins (IgG, IgA, IgM), lactoferrin, and insulin-like growth factor-1 (IGF-1). Its bioactive compounds are studied primarily for passive immune transfer in neonatal piglets, with no controlled human clinical trials establishing efficacy or safety in adults.

Origin & History

Pig colostrum is the initial secretion produced by the mammary glands of sows immediately after farrowing, collected within the first hours postpartum through manual or mechanical extraction. It is a protein-rich immunological secretion containing elevated concentrations of proteins, immunoglobulins, growth factors, and bioactive peptides, with lower fat and lactose content compared to mature sow milk.

Historical & Cultural Context

The research results do not contain any information about historical or traditional use of pig colostrum in traditional medicine systems. Available sources focus exclusively on modern agricultural and veterinary applications.

Health Benefits

• No human health benefits documented - available research focuses exclusively on piglet nutrition
• Contains high protein concentrations including whey proteins (animal studies only)
• Rich in immunoglobulins and growth factors (compositional data only, no human trials)
• Components absorbed via nonspecific pinocytosis in newborns (mechanism studied in animals only)
• Contains lactose-synthesizing proteins including alpha-lactalbumin/LALBA (biochemical characterization only)

How It Works

Porcine colostrum delivers immunoglobulins—primarily IgG—that bind pathogen surface antigens to facilitate opsonization and complement activation in neonatal piglets, whose gut epithelium transiently permits macromolecular transcytosis via FcRn (neonatal Fc receptor) during the first 24–36 hours of life. IGF-1 and transforming growth factor-beta (TGF-β) present in the colostrum activate PI3K/Akt and SMAD signaling pathways, respectively, supporting intestinal villus development and tight-junction protein expression (claudin-3, occludin) in piglets. In adult humans, gut epithelial permeability to intact immunoglobulins is markedly reduced, meaning these large proteins are largely degraded by proteolysis before systemic absorption, making direct immune transfer mechanistically implausible outside the neonatal window.

Scientific Research

No peer-reviewed human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs evaluating pig colostrum as a therapeutic supplement in humans were found in the research. All available studies focus on compositional analysis for animal nutrition and laboratory methodology for measuring milk components rather than human clinical efficacy.

Clinical Summary

No peer-reviewed human randomized controlled trials have been published specifically examining oral pig colostrum supplementation in healthy or clinical adult populations. Existing research is confined to neonatal piglet studies—such as comparisons of colostrum volume and IgG concentration effects on piglet survival and growth rates—and compositional analyses characterizing protein fractions, lactoferrin (~1–2 mg/mL), and IgG concentrations (ranging roughly 50–100 mg/mL in early porcine colostrum). Human research on colostrum supplementation has focused almost exclusively on bovine colostrum (Bos taurus), from which findings cannot be reliably extrapolated to porcine sources due to species-specific glycosylation patterns and immunoglobulin subclass differences. The overall evidence base for pig colostrum as a human supplement is rated very low quality, and no regulatory health claims have been approved by the FDA or EFSA.

Nutritional Profile

Pig colostrum (Sus scrofa domesticus) is a nutrient-dense secretion produced in the first 24–48 hours postpartum, with composition shifting rapidly over time. **Macronutrients (approximate, per 100 mL first-milking colostrum):** Total protein: 15–18 g (dramatically higher than mature sow milk at ~5–6 g/100 mL); Fat: 5–7 g (rich in saturated and monounsaturated fatty acids, with modest polyunsaturated content including linoleic acid ~0.5–0.8 g); Lactose: 2.5–3.5 g (lower than mature milk at ~5 g, as lactose synthesis ramps up postpartum via α-lactalbumin-dependent lactose synthase); Total solids: 25–28%. **Protein fractions:** Immunoglobulins dominate, comprising ~60–70% of total protein — IgG: 60–95 mg/mL (primary class, predominantly IgG1); IgA: 10–25 mg/mL (secretory form); IgM: 3–10 mg/mL. Whey proteins include β-lactoglobulin (~3–5 mg/mL), α-lactalbumin (~1–2 mg/mL), lactoferrin (~1–2 mg/mL), and serum albumin (~2–3 mg/mL). Casein content is relatively low in first colostrum (~3–5 g/100 mL) but increases as lactation progresses. **Bioactive compounds and growth factors:** Insulin-like Growth Factor-I (IGF-I): ~200–500 ng/mL (among the highest of domestic species); Insulin-like Growth Factor-II (IGF-II): ~40–60 ng/mL; Epidermal Growth Factor (EGF): ~100–300 ng/mL; Transforming Growth Factor-β (TGF-β): ~20–50 ng/mL; Insulin: ~5–10 µg/mL (substantially elevated vs. mature milk). **Minerals (per 100 mL):** Calcium: ~70–90 mg; Phosphorus: ~100–120 mg; Magnesium: ~8–12 mg; Sodium: ~60–80 mg (elevated vs. mature milk); Potassium: ~80–110 mg; Iron: ~0.1–0.2 mg; Zinc: ~0.8–1.5 mg (higher than mature milk). **Vitamins:** Vitamin A (retinol): ~0.1–0.3 mg/100 mL; Vitamin E (α-tocopherol): ~0.3–0.8 mg/100 mL; Vitamin D: trace amounts; B-vitamins present in modest concentrations (B12 ~0.01–0.05 µg/mL; riboflavin ~0.3–0.5 µg/mL). Fat-soluble vitamin concentrations are significantly higher in colostrum than mature milk. **Additional bioactive components:** Oligosaccharides (sialyllactose, fucosyllactose derivatives): present at ~5–10 g/L, declining rapidly post-colostral; Lysozyme: ~0.04–0.1 mg/mL; Complement factors (C3, C4); Cytokines (IL-6, TNF-α in ng/mL range); Leukocytes: ~1 × 10⁶ cells/mL (neutrophils, macrophages, lymphocytes). **Bioavailability notes:** In neonatal piglets, macromolecular absorption (immunoglobulins, growth factors) occurs via nonspecific intestinal pinocytosis during the first 24–36 hours of life ('gut closure' thereafter). In adult animals or humans, these large proteins would be subject to proteolytic degradation in the stomach and small intestine, drastically reducing bioavailability of intact immunoglobulins and growth factors. Minerals such as zinc and iron may have moderate bioavailability due to binding with casein phosphopeptides and lactoferrin. No standardized bioavailability data exist for human consumption of pig colostrum; all compositional values are derived from veterinary and animal science literature.

Preparation & Dosage

No clinically studied dosage ranges for pig colostrum supplements in human use are available in the research. No information on standardized extract concentrations or dosing protocols for different formulations was found. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of human supplementation research

Safety & Interactions

Because no human safety trials exist for oral pig colostrum supplementation, its adverse effect profile in people is not formally established. Individuals with pork or mammalian meat allergies (including alpha-gal syndrome triggered by galactose-alpha-1,3-galactose present in porcine glycoproteins) face a meaningful allergic reaction risk, ranging from urticaria to anaphylaxis. Theoretical interactions with immunosuppressive medications (e.g., cyclosporine, tacrolimus) exist if any bioactive immune-modulating peptides survive digestion, though this remains speculative given poor intact protein absorption in adults. Pregnant or breastfeeding individuals should avoid pig colostrum supplements entirely due to the complete absence of safety data in these populations.